Initiating biologics and biosimilars in practice: approach and consultation guidance Considerations for initiating biologic and biosimilar medicines, including the relevant clinical pathways and patient counselling.…
More than a quarter of patients overusing rescue inhalers for asthma, study finds Researchers from Queen Mary University London warned that salbutamol inhalers can increase risk of anxiety and tachycardia.…
Metered-dose inhaler classed as ‘carbon neutral’ through offsetting Lupin Healthcare, which manufactures the Luforbec inhaler, offsets the total emissions produced from production, use and disposal of the inhaler, making it carbon neutral.…
Ministers need a new approach to generic medicines Despite underpinning the fight against COVID-19, generic and biosimilar medicines do not get the attention they deserve from the UK government.…
How switching a handful of patients’ inhalers saved nearly 5,000kgCO2e While switching inhalers may not be for everyone, reviewing patients who may benefit from a lower carbon device could have an enormous impact.…
Some patients switched to ‘greener’ inhalers without consultation, say experts Exclusive: Experts warn that non-consented inhaler switches pose risks to patients' health and advise physicians to carry out individual inhaler checks to avoid this.…
Spike in price concessions prompts concern over generic medicine supply issues Exclusive: As the number of price concessions for generic drugs soared in January 2022, the Pharmaceutical Services Negotiating Committees has raised concerns with the government over supply issues.…
Switches to dry powder inhalers could halve carbon footprint, study results suggest Patients switched to a dry powder inhaler produced 132kg less annual carbon dioxide equivalent than those using metred-dose inhalers, and had better asthma control.…
Minister urged to block takeover of inhaler manufacturer by tobacco firm The Royal Pharmaceutical Society has written to the government to express its concerns around the proposed takeover of inhaler manufacturer Vectura by tobacco company Philip Morris International.…
Learnings from observing a Chinese medicine clinic during the initial stages of the COVID-19 pandemicThe views expressed in this letter are those of the author’s. If you would like to submit a letter to The Pharmaceutical Journal, please click here. When the COVID-19 epidemic raged around the world, I had the opportunity to record the experience from a traditional Chinese medicine (TCM) clini…
